1AROLA A,KALLAJOKI M,RUUSKANEN O,et al.Petection of enteroviral RNA in end-stage dilated cardiomyopathy in children and adolescents[J].J Med Virol,1998,56:364-371.
2DALEKOS G N,ACHENBACH K,CHRISTODOULOU D,et al.Idiopathic dilated cardiomyopathy:lack of association with hepatitis Cvirus infection[J].Heart,1998,80:270-275.
3LIANG-XING F,YVONNE M,CLAES-HAKAN B,et al.Localization of a functional antoinmune epitope on the muscarinic acetylcho-line receptor-2 in the patients with idiopathic dilated cardiomyopathy[J].J Clin Invest,1993,91:1964-1968.
4YVONNE M,STEFANO M,SOREN H,et al.Mapping of a functional antoimmune epitope on the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy[J].J Clin Invest,1990,86:1658-1663.
6BENGEL F M,PERMANETTER B,UNGERER M,et al.Relationship between altered sympathetic innervation,oxidative metabolism and contractile function in the cardiomyopathic human heart:a non-invasive study using positron emission tomography[J].Eur Heart J,2001,22:1594-1600.
7YOUNG A A,DOKOS S,POWELL K A,et al.Regional heterogeneity of function in nonischemic dilated cardiomyopathy[J].Cardiovasc Res,2001,49:308-318.
8KIVIKKO M,LEHTONEN L.Sustained hemodynamic effects of intravenous levosimendan[J].Circulation,2003,107:81-86.
9MATSUMURA S T,TSUSHIMA K,OHTAKI E,et al.Effects of carvedilol on plasma levels of IL-6 and TNF-2 in nine patients with dilated cardiomyopathy[J].J Cardiol,2002,39(5):253-257.
10OSTERZIEL K J,RANKE M B,STROHM O,et al.The Somatotrophic system in patients with dilated cardiomyoparhy:relation of insulin-like growth factor-1and its qlterations during growth hormone therapy to cardial function[J].Clin Endocri,2000,53(1):61-68.
